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Dishevelled (DVL) proteins serve as crucial regula-
tors that transduce canonical Wnt signals to the
GSK3b-destruction complex, resulting in the stabili-
zation of b-catenin. Emerging evidence underscores
the nuclear functions of DVLs, which are critical for
Wnt/b-catenin signaling. However, the mechanism
underlying DVL nuclear localization remains poorly
understood. Here we discovered two Forkhead box
(FOX) transcription factors, FOXK1 and FOXK2, as
bona fide DVL-interacting proteins. FOXK1 and
FOXK2 positively regulate Wnt/b-catenin signaling
by translocating DVL into the nucleus. Moreover,
FOXK1 and FOXK2 protein levels are elevated
in human colorectal cancers and correlate with
DVL nuclear localization. Conditional expression of
Foxk2 in mice induced intestinal hyper-proliferation
that featured enhanced DVL nuclear localization
and upregulated Wnt/b-catenin signaling. Together,
our results not only reveal a mechanism by which
DVL is translocated into the nucleus but also suggest
unexpected roles of FOXK1 and FOXK2 in regulating
Wnt/b-catenin signaling.
INTRODUCTION
The Wnt/b-catenin pathway is an essential signaling pathway
that directs cell proliferation, self-renewal, differentiation, tis-
sue homeostasis, and embryonic development (Clevers, 2006;
Clevers and Nusse, 2012; Huang and He, 2008; Nusse, 2008).
Deregulation of the Wnt/b-catenin pathway contributes to hu-
man degenerative disease and tumorigenesis in various tissues
(Clevers, 2006; Clevers and Nusse, 2012; Moon et al., 2004;
Nusse, 2005). Wnt ligands initiate the signaling pathway by bind-
ing to Frizzled and LRP receptors present at the cell surface and,
thereby, stimulate a series of biological events inside the cell.
The core component of the canonical Wnt pathway is the tran-
scriptional co-activator b-catenin, which is regulated at the pro-
tein level by proteasome-dependent degradation via the b-TRCP
E3 ubiquitin ligase complex (Aberle et al., 1997). The degradationDeveloof b-catenin is governed by a cytoplasmic destruction complex
that includes components such as the tumor suppressor pro-
teins AXIN and APC and members of two groups of kinases,
CK1 and GSK3. Activation of Wnt signaling represses the
destruction complex and, thereby, stabilizes b-catenin, which
translocates into the nucleus to assemble a transcriptionally
active complex with TCF or LEF to promote the transcription
of many Wnt downstream target genes (e.g., Axin2, c-Myc,
and cyclin D1) (Clevers, 2006; Moon et al., 2004).
Dishevelled (DVL) is a critical scaffold protein that acts be-
tween Frizzled receptors and the destruction complex. Although
the detailed mechanisms remain to be elucidated, activation
of the Wnt pathway leads to the phosphorylation of DVL,
which then suppresses the downstream destruction complex
to stabilize b-catenin (Clevers, 2006; Nusse, 2005). Intriguingly,
emerging evidence suggests that DVL also plays a pivotal role
in the nucleus by mediating the formation of the b-catenin/TCF
transcriptional complex in conjunction with c-Jun, which is
required for Wnt/b-catenin signaling (Barry et al., 2013; Gan
et al., 2008; Habas and Dawid, 2005; Itoh et al., 2005; Torres
and Nelson, 2000). In addition, Wnt stimulation promotes DVL
nuclear translocation (Gan et al., 2008; Itoh et al., 2005), which
appears to act in parallel to its cytoplasmic functions for activa-
tion of the Wnt signaling pathway. Moreover, in vivo evidence
revealed that DVL localizes to the nucleus of the intestinal
crypt base column (CBC), and this DVL nuclear localization is
enhanced by Wnt signaling during intestine regeneration (Barry
et al., 2013). Intriguingly, the Hippo pathway components YAP
and TAZ negatively control DVL nuclear functions by seques-
tering it in the cytoplasm through direct protein-protein interac-
tions and also inhibit CK1 kinase-mediated DVL phosphorylation
(Barry et al., 2013; Varelas et al., 2010). These findings indicate
that nuclear DVL is critical for activation of the Wnt/b-catenin
signaling pathway, but the regulatory mechanism underlying
DVL nuclear translocation remains largely unknown.
In this study, we identified two Forkhead box (FOX) transcrip-
tion factors, FOXK1 and FOXK2, as DVL-associated proteins.
We demonstrate that FOXK proteins activate Wnt/b-catenin
signaling by promoting DVL nuclear translocation, which re-
quires Wnt signaling-induced DVL phosphorylation. Moreover,
we show that FOXK protein expression is increased signifi-
cantly in human colon cancers and correlates with DVL nuclear
localization. Finally, conditional expression of Foxk2 using a
transgenic mouse model induced intestinal hyper-proliferation,pmental Cell 32, 707–718, March 23, 2015 ª2015 Elsevier Inc. 707
Figure 1. FOXK1 and FOXK2 Are DVL-Associated Proteins and Promote DVL Nuclear Translocation
(A) Identification of the DVL-FOXK complex through tandem affinity purification-MS analysis. HEK293T cells stably expressing SFB-tagged DVL2, DVL3, FOXK1,
or FOXK2 were used for tandem affinity purification to identify associated protein complexes. The interaction network (with hand-picked preys) within the DVL-
FOXK complex was subjected to illustration by Cytoscape. The peptide information identified by the mass spectrometry analysis for the DVL-FOXK complex is
summarized in the table.
(B) The interaction between DVL and FOXK was confirmed by pull-down Western Blot analysis. The SFB-DVL2 and DVL3 purification elutes were analyzed by
FOXK1 and FOXK2 antibodies.
(C) FOXK associates with all members of DVL family. GFP-tagged DVL1/2/3 was co-expressed with SFB-tagged FOXK2 in HEK293T cells, and cell lysates were
subjected to pull-down assays with S protein beads.
(legend continued on next page)
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nuclear translocation of DVL, and upregulation of Wnt/b-catenin
signaling in intestinal crypts. Together, our results demonstrate a
potential oncogenic function of FOXK proteins via their ability to
translocate DVL into the nucleus and activate the Wnt/b-catenin
signaling pathway.
RESULTS
FOXK1 and FOXK2 Are DVL-Binding Proteins
To identify DVL-associated proteins that may facilitate DVL nu-
clear translocation, we performed tandem affinity purification
using HEK293T cells stably expressing SFB-tagged (S protein
tag, FLAG tag, and streptavidin-binding tag) DVL2 or DVL3 as
described previously (Wang et al., 2014). Many known DVL-
binding proteins have been identified by mass spectrometry
analysis, including canonical Wnt pathway components (i.e.,
AXIN1, AXIN2, GSK3B, and b-TRCP) (Clevers, 2006), non-ca-
nonical Wnt pathway components (i.e., VANGL1 and VANGL2)
(Torban et al., 2004), an E3 ligase complex component
(KLHL12) (Angers et al., 2006), and other reported DVL-binding
partners (e.g., WWOX and CK1) (Bouteille et al., 2009; Walling-
ford and Habas, 2005) (Figure 1A). Interestingly, we also identi-
fied two FOX transcription factors, FOXK1 and FOXK2, in our
biologically triplicated mass spectrometry analyses (Figure 1A),
suggesting that FOXK1 and FOXK2 are potential DVL-binding
proteins. We performed reverse purification using FOXK1 or
FOXK2 as bait and uncovered all members of the DVL protein
family, DVL1, DVL2, and DVL3, as FOXK1- or FOXK2-associated
proteins (Figure 1A). The detailed peptide information is listed as
a table in Figure 1A. The interactions between DVL and FOXK
proteins were further confirmed by co-immunoprecipitation
experiments (Figures 1B and 1C). Moreover, the FOXK-DVL
interaction is highly specific within the Wnt signaling pathway
(Figure 1D) and among the FOX transcription factor family (Fig-
ure 1E), which demonstrates the specificity of this interaction.
Collectively, these data indicate that FOXK1 and FOXK2 are
bona fide DVL-binding partners.
FOXK1 and FOXK2 Promote DVL Nuclear Translocation
Because FOXK1 and FOXK2 are nuclear proteins, we wondered
whether FOXK1and FOXK2could regulateDVL subcellular local-
ization. Indeed, overexpression of either FOXK1 or FOXK2 en-(D and E) The association between FOXK and DVL is specific in the Wnt pathwa
(F) FOXK translocates DVL into the nucleus. Endogenous DVL2 was detected in
cated the FOXK-positive and -negative cells. The nucleus was visualized by DAP
(G) The specificity of the FOXK2-mediated DVL2 nuclear translocation. GFP-DVL2
cells. The localization of GFP-DVL2 was detected by immunostaining.
(H) Schematic of human DVL2 protein domains and the region required for FOXK
(I) Determination of the region of DVL2 required for the FOXK2 interaction. Va
HEK293T cells for 24 hr, and cell lysates were subjected to pull-down assays wi
(J) The PDZ domain and IVLT motif on DVL2 are required for FOXK2 binding. GFP
FOXK2 in HEK293T cells, and cell lysates were subjected to pull-down assays.
(K) Both the PDZ domain and the IVLT motif on DVL2 are required for FOXK2-m
(L) Schematic of human FOXK2 protein domains and the region required for DVL
(M and N) The FHA domain and its adjacent region (129171 amino acids) of FO
amino acids) on FOXK1 is also required for the interaction with DVL2.
(O and P) Three hydrophobic amino acids (Leu-137, Phe-145, and Phe-154) on FO
mutations of FOXK2 were co-expressed for 24 hr with GFP-DVL2 in HEK293T c
(Q) The FHA domain and the identified three amino acids are required for FOXK
mutants were co-expressed in HeLa cells. The localization of GFP-DVL2 and SF
Develohanced the nuclear localization of endogenous DVL2, whereas
DVL2 mostly localized to the cytoplasm of untransfected cells
(Figure 1F; Figures S1A–S1C). Consistent with the specific inter-
action between FOXKs andDVLs (Figure 1E), only FOXK proteins
were capable of translocating DVL into the nucleus (Figure 1G).
These results indicate that FOXK1 and FOXK2 may regulate
DVL nuclear localization.
Mapping of the Binding Regions Required for the
FOXK-DVL Interaction
To further elucidate the FOXK-binding region on DVL, a series of
DVL2 truncation mutants was generated (Figure 1H) where a re-
gion comprised of residues 250355 of DVL2 is required for its
interaction with FOXK2 (Figure 1I). This region includes the
PDZ domain and a four-amino acid motif, IVLT, which has
been reported previously to be required for DVL nuclear import
(Itoh et al., 2005; Figure 1H). Deletion of either the PDZ domain
or the IVLT motif disrupted the association of DVL2 with
FOXK2 (Figure 1J) as well as FOXK2-mediated DVL2 nuclear
translocation (Figure 1K). Conversely, the forkhead-associated
(FHA) domain and its adjacent region (residues 129171) on
FOXK2 are required for its binding to DVL2 (Figures 1L and
1M). This FHA-adjacent region is conserved between FOXK1
and FOXK2, where deletion of this region on either FOXK1or
FOXK2 disrupted its association with DVL (Figure 1N). Moreover,
a hydrophobic motif (Leu-137-Phe-145-Phe-154) within this re-
gion was also required for the binding of FOXKs to DVL2 (Figures
1O and 1P). In addition, the ability of FOXK to promote DVL nu-
clear translocation correlates with its capability to associate with
DVL (Figure 1Q). These data suggest that the PDZ domain-
located region (residues 250355) of DVL and the hydrophobic
motif adjacent to the FHA domain of FOXK are required for their
interaction.
FOXK1 and FOXK2 Positively Regulate Wnt/b-Catenin
Signaling by Translocating DVL into the Nucleus
Previous studies have suggested that nuclear DVL enhances
Wnt signaling by stabilizing the b-catenin/TCF transcription
complex, which is required for Wnt/b-catenin signaling (Gan
et al., 2008; Itoh et al., 2005). Because FOXK1 and FOXK2 pro-
mote DVL nuclear translocation, we wondered whether FOXK1
and FOXK2 are involved in the regulation of Wnt/b-cateniny and FOX transcription factor family.
HEK293T cells transfected with FLAG-tagged FOXK1 or FOXK2. Arrows indi-
I staining. M, merged.
and various SFB-tagged FOX transcription factors were co-expressed in HeLa
2 binding.
rious GFP-tagged DVL2 truncations were co-expressed with SFB-FOXK2 in
th S protein beads.
-tagged DVL2 PDZ or IVLT deletion constructs were co-expressed with SFB-
ediated nuclear translocation.
2 binding.
XK2 are required for the association to DVL2. The conserved region (176214
XK2 are required for the interaction with DVL2. Various deletions and single site
ells, and cell lysates were subjected to a pull-down assay.
2-mediated DVL2 nuclear translocation. GFP-DVL2 and the indicated FOXK2
B-FOXK2 mutants was detected by immunostaining. See also Figure S1.
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Figure 2. FOXK Proteins Activate the Wnt Pathway by Promoting Nuclear Translocation of DVLs
(A) Knockdown of FOXK1 and FOXK2 in HEK293T and HT29 cells. Endogenous FOXK1 and FOXK2 expression was detected in the indicated short hairpin RNA
(shRNA)-transduced cells.
(B) Loss of FOXK1 and FOXK2 suppressed b-catenin transcriptional activity. The transcript of AXIN2 was detected by qPCR in HEK293T and HT29 cells
transduced with the indicated shRNA (n = 3, mean ± SD). For HEK293T cells, Wnt signaling was activated by treatment with 25 mM LiCl for 6 hr.
(legend continued on next page)
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signaling. Indeed, loss of FOXK1 or FOXK2 in HEK293T cells
suppressed LiCl-induced transcription of the Wnt target gene,
i.e., AXIN2, whereas double knockdown of FOXK1 and FOXK2
further suppressed it (Figures 2A and 2B; Figure S2A). Similar re-
sults were also observed in HT29 colon cancer cells (Figures 2A
and 2B; Figure S2B). Moreover, loss of FOXK suppressed
TOPFLASH luciferase activity (Figure 2C). These data indicate
that FOXK1 and FOXK2 are required for Wnt/b-catenin signaling.
Additionally, overexpression of FOXK1 or FOXK2 promoted
LiCl-induced TOPFLASH luciferase activity, and this stimulation
was inhibited by the b-catenin/TCF complex inhibitor of b-cate-
nin-responsive transcription 14 (iCRT-14) (Figure 2D), which
further supports the positive roles of FOXK1 and FOXK2 in
Wnt/b-catenin signaling regulation. Notably, this regulation is in-
dependent of FOXK1 and FOXK20s DNAbinding activity because
their DNA-binding mutants were still able to bind and translocate
DVL into the nucleus (Figures S2C and S2D) and facilitate LiCl-
induced TOPFLASH luciferase activity (Figure 2E). However,
either mutation of the FOXK2 hydrophobic residues or deletion
of the FHA domain-adjacent region abolished the ability of
FOXK2 to promote LiCl-induced TOPFLASH luciferase activity
(Figure 2F), suggesting that association with DVL protein is
required for the FOXK-mediated positive regulation of Wnt/
b-catenin signaling. Importantly, knockdown of DVL suppressed
FOXK-induced TOPFALSH luciferase activity (Figures 2G and
2H), indicating that this FOXK-mediated Wnt/b-catenin activa-
tion depends on DVL.
Because FOXK1 and FOXK2 promote the nuclear transloca-
tion of DVL (Figure 1F), we next asked whether depletion of
FOXK1 and FOXK2 would inhibit the nuclear localization of
DVL. Consistent with previous findings, Wnt3A treatment in-
creased the nuclear fractionation of DVL2 (Gan et al., 2008;
Itoh et al., 2005; Figure 2I). However, we could hardly detect nu-
clear DVL2 in either basal or Wnt3A-treated FOXK1 and FOXK2
double knockdown cells (Figure 2I). Moreover, inhibition of the(C) Loss of FOXK1 and FOXK2 suppresses TOPFLASH luciferase reporter activity
where pSV40-Renilla was used as internal control (n = 3, mean ± SD). TOP-F
respectively.
(D) FOXK proteins promote Wnt/b-catenin reporter activity. HEK293T cells were t
for 6 hr with or without iCRT-14 (100 mM). A luciferase assay of b-catenin transcript
(n = 3, mean ± SD).
(E) The transcriptional activities for FOXK proteins are dispensable for Wnt/b-cate
transiently transfecting HEK293T cells with the indicated FOXK plasmids and the
for 6 hr.
(F) The association with DVL2 is required for FOXK-mediated Wnt/b-catenin pat
siently transfecting HEK293T cells with the indicated FOXK site mutations or inte
(G and H) FOXK activates the Wnt/b-catenin pathway through DVL. TOPFLASH
plasmids in control shRNA-transduced HEK293T cells and DVL2/3 shRNA-transd
examined in both control and DVL2/3 shRNA-transduced HEK293T cells by wes
(I) Loss of FOXK proteins inhibits Wnt3A-induced DVL nuclear translocation. Cellu
were treated with Wnt3A conditioned medium (Wnt3A-CM) for 8 hr. The indicate
(J and K) Loss of FOXK proteins inhibits DVL nuclear translocation. DVL2 localiza
DVL2 nuclear accumulation was enhanced by treatment with 50 ng/ml LMB for 1
expression was examined by western blot (K).
(L and M) Nuclear DVL2 promotes b-catenin reporter activity. Three tandem NLS
TOPFLASH luciferase activity (n = 3, mean ± SD). HEK293T cells were treated w
(N–Q) Nuclear DVL2 rescued Wnt/b-catenin signaling in FOXK1- and FOXK2-de
in FOXK1- and FOXK2-deficient HEK293T (N) and HT29 cells (P) by western blo
mean ± SD). For HEK293T cells, Wnt signaling was activated by treatment with
**p < 0.01, ***p < 0.001 (Student’s t test). See also Figure S2.
Develonuclear export machinery by treatment with leptomycin B
(LMB) increased nuclear localization of DVL2. However, this
was not the case in FOXK1 and FOXK2 double knockdown cells
(Figures 2J and 2K). Furthermore, artificially translocating DVL
into the nucleus by fusing DVL2 with an additional nuclear local-
ization signal (NLS) (Figure 2L) was sufficient to promote LiCl-
induced TOPFLASH luciferase activity (Figure 2M) and partially
rescued the suppression of Wnt signaling in HEK293T and
HT29 cells (Figures 2N–2Q). These data together support our
conclusion that FOXK1 and FOXK2 are required for the nuclear
translocation of DVL, which then activates Wnt/b-catenin sig-
naling in the nucleus.
To gain further insights into the role of FOXK in the Wnt/b-cat-
enin signaling pathway, we used Xenopus laevis embryos for
axis duplication assays (Funayama et al., 1995). Only FOXK2,
but not FOXK1, can be identified in Xenopus laevis. The effect
of Xenopus FOXK2 (xFoxk2) on Wnt signaling was monitored
by secondary axis formation following injection of in vitro-tran-
scribed mRNAs. First we examined the association between
FOXK2 and DVL2 in Xenopus laevis. As shown in Figure 3A,
although wild-type xFoxk2 and its DNA-binding mutant associ-
ated with Xenopus DVL2 (xDvl2), mutation of the FHA domain-
adjacent region in xFoxk2 (residues 92134) or one of the noted
hydrophobic residues (L100A in xFoxk2) disrupted the binding of
xFoxk2 with xDvl2, indicating that the DVL-FOXK interaction is
conserved in Xenopus laevis. Second, xb-catenin mRNA, which
was titrated to a sub-phenotypic level, as described previously
(Jung et al., 2013), was co-injected with xFoxk2mRNA into ven-
trovegetal blastomeres. Co-injection of xFoxk2 with xb-catenin
led to the formation of a duplicated axis, but this was not
observed when b-galactosidase control mRNA was co-injected
with xb-catenin (Figures 3B and 3C). Interestingly, mRNA encod-
ing the xFoxk2-L100Amutant (Figure 3A) failed to induce axis du-
plications when co-injected with xb-catenin mRNA (Figures 3C
and 3D), suggesting that association with xDvl is required for. A TOPFLASH luciferase reporter assay was performed in the indicated cells,
LASH and FOP-FLASH indicate pMegaTOPFLASH and pMegaFOPFLASH,
ransiently transfected with the indicated plasmids and treated with 25 mM LiCl
ional activity was performed, where pSV40-Renillawas used as internal control
nin pathway activation. b-catenin luciferase reporter assays were performed by
ir DNA-binding mutants (n = 3, mean ± SD). Cells were treated with 25 mM LiCl
hway activation. b-catenin luciferase reporter assays were performed by tran-
rnal deletions (n = 3, mean ± SD). Cells were treated with 25 mM LiCl for 6 hr.
luciferase reporter assays were performed by transiently transfecting FOXK2
uced HEK293T cells (n = 3, mean ± SD) (H). The DVL2 and DVL3 proteins were
tern blot (G). Cells were treated with 25 mM LiCl for 6 hr.
lar fractionation of shRNA-transduced HEK293T cells was performed. The cells
d proteins were detected by western Blot.
tion was detected by immunostaining in shRNA-transduced HEK293T cells (J).
2 hr. The percentage of nuclear DVL2 was quantified in 200 cells. DVL2 protein
s were fused to DVL2, which translocated DVL2 into the nucleus and activated
ith 25 mM LiCl for 6 hr.
ficient HEK293T and HT29 cells. The expression of NLS-DVL2 was examined
t. The transcript of AXIN2 was detected by qPCR in the indicated cells (n = 3,
25 mM LiCl for 6 hr.
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Figure 3. FOXK Proteins Are Required for Tumorigenesis of Colon Cancer Cells
(A) The association between FOXK2 andDVL2 is conserved in Xenopus.XenopusDvl2 and the indicated Xenopus Foxk2mutants were co-expressed in HEK293T
cells for 24 hr, and cell lysates were subjected to pull-down assays.
(B–D) xFoxk2-induced b-catenin activation leads to axis duplication. xFoxk2 or xFoxk2-L100AmRNA was injected with xb-cateninmRNA into the ventrovegetal
blastomeres of Xenopus laevis embryos, where b-galactosidase was taken as a control. Secondary axes were examined from neurulation (B) through tail bud
stages (C) and quantified (D).
(E and F) Loss of FOXK inhibits cell proliferation (n = 3, mean ± SD) and xenograft tumor formation for HT29 colon cancer cells (n = 5 mice, mean ± SD).
(G–I) Wild-type FOXK1 or FOXK2, but not the FOXK2-L137A mutant, rescued cell proliferation (n = 3, mean ± SD) and xenograft tumor formation (n = 8 mice,
mean ± SD) in FOXK1/2-Knockout (KO)-DLD-1 cells. The DLD-1 FOXK-KO cells were generated using the clustered regularly interspaced short palindromic
repeats (CRISPR) approach. The FOXKproteins were detected in the indicated cells (G). The cell growth curve (H) and tumor weight (I) were analyzed (mean ± SD).
ns, no significant difference. The asterisk indicates a nonspecific band.
(J) Proliferation and Wnt/b-catenin signaling were suppressed in FOXK1/2 knockdown (F) or knockout (I) xenograft tumors. Immunohistochemistry was per-
formed with the indicated antibodies in HT29 and DLD-1 xenograft tumors.
(K–N) NLS-DVL2, but not DVL2 or b-catenin, promoted Wnt signaling in FOXK1- and FOXK2-deficient DLD-1 cells. The indicated proteins were reconstituted in
FOXK1/2-knockout DLD-1 cells and examined by western blot (K). TOPFLASH luciferase reporter assays were performed in the indicated cells (n = 3, mean ± SD)
(L). The indicated cells were subjected to a xenograft study. Xenograft tumors are shown in (M), and the tumorweight was quantified in (N) (n = 8mice, mean ± SD).
**p < 0.01, ***p < 0.001 (Student’s t test).this activity of xFoxk2. Notably, the fact that ventrovegetal injec-
tion of xFoxk2 alone failed to induce axis duplication (data not
shown) indicates that active b-catenin is required for the positive
roles of xFoxk2 in Wnt signaling. This finding is consistent with712 Developmental Cell 32, 707–718, March 23, 2015 ª2015 Elsevierprevious results showing that FOXK1 and FOXK2 only promoted
Wnt/b-catenin signaling in HEK293T cells treated with LiCl (Fig-
ure 2D). These data suggest that Foxk2 activates Wnt/b-catenin
signaling during early embryogenesis.Inc.
In human colorectal cancers (CRC), activation of Wnt/b-cate-
nin signaling is usually associated with elevated b-catenin levels
and activity because of mutations of the APC tumor suppressor
or of b-catenin itself (Clevers and Nusse, 2012). We showed that
loss of FOXK1 and FOXK2 suppressed Wnt signaling in HT29
colon cancer cells (Figures 2B and 2C), suggesting a potential
positive role of FOXK1 and FOXK2 in CRCs. Indeed, loss of
FOXK1 and FOXK2 in two independent colon cancer cell lines
(HT29 and DLD-1) inhibited cell proliferation and xenograft
tumor growth (Figures 3E–3I). Further immunohistologic analysis
showed that tumors driven from FOXK1 and FOXK2-deficient
HT29 or DLD-1 cells exhibited decreased proliferation (Ki67
staining) and downregulated Wnt/b-catenin signaling (e.g.,
CD44 staining) (Figure 3J). Reconstitution of wild-type FOXK1
or FOXK2 rescued cell proliferation and xenograft tumor growth
in FOXK1 and FOXK2-deficient DLD-1 cells, but this was not the
case in cells reconstituted with the FOXK2-L137A mutant (Fig-
ures 3G–3I). To address the role of nuclear DVL in this process,
NLS-DVL2 (Figure 2L) was expressed in FOXK1- and FOXK2-
deficient DLD-1 cells (Figure 3K). In agreement with previous
cell line studies (Figures 2N–2Q), this artificial NLS-DVL2 expres-
sion in FOXK1 and FOXK2-deficient DLD-1 cells was also able to
promote TOPFLASH luciferase activity (Figure 3L) and xenograft
tumor growth (Figures 3M and 3N), indicating that the oncogenic
functions of FOXK proteins in colon cancer cells may be, at least
in part, mediated by their abilities to promote DVL nuclear trans-
location. Interestingly, DVL2 or b-catenin expression (Figure 3K)
failed to rescue TOPFLASH luciferase activity (Figure 3L) or
xenograft tumor growth (Figures 3M and 3N) in FOXK1/2-defi-
cient DLD-1 cells, suggesting that FOXK-dependent activation
of Wnt signaling is mainly mediated by DVL nuclear localization.
The Interaction between DVL and FOXK Is Regulated by
DVL Phosphorylation
Next we investigated the mechanism underlying DVL-FOXK
complex formation. A previous study has shown that Wnt3A
treatment increases the nuclear localization of DVL (Itoh et al.,
2005). Consistent with this early finding, we showed that the
interaction between DVL2 and FOXK1 or FOXK2 was increased
followingWnt3A treatment (Figure 4A).Wnt3A treatment induced
phosphorylation of DVL, which was marked by slower migration
of DVL in SDS-PAGE (Figure 4A). Interestingly, we found that the
phosphorylation of DVL2 is required for its binding to FOXK2
because DVL2 treatment with l protein phosphatase disrupted
its interaction with FOXK2, whereas the same treatment of
FOXK2 did not affect FOXK2-DVL2 interaction (Figure 4B). More-
over, we found that all hydrophobic site mutations on FOXK2
also disrupted the binding of FOXK2 to SDS3, which is a known
FOXK-associated phosphoprotein that binds to FOXK via the
FOXK FHA domain (Shi et al., 2012; Figure 4C). This indicates
that the hydrophobic motif on FOXK identified previously may
function together with its adjacent FHA domain. Together, these
data suggest that Wnt3A-induced DVL phosphorylation pro-
motes the DVL-FOXK interaction.
Given that the FOXK2-binding region on DVL2 was identified
(Figures 1H and 1I), we wished to further define the phosphory-
lation sites within this region that are required for the DVL2-
FOXK2 interaction. There are 18 potential phosphorylation sites
in this region (Figure 4D), where Thr-350 is not required (data notDeveloshown). We mutated them one by one, or in groups if these sites
were adjacent to each other, and found that four grouped phos-
phorylation sites (M1–M4) are required for the binding of DVL2 to
FOXK2 (Figure 4E). Furthermore, mutating all 11 sites in these
four groups abolished the association of DVL2 with FOXK2 (Fig-
ure 4F), whereas individual mutation of each Ser or Thr site only
partially decreased the binding of DVL2 to FOXK2 (Figure 4F). Of
note, 10 of 11 sites identified here are evolutionarily conserved in
all three DVL proteins, where two of them (Thr-267 and Thr-269)
locate within the PDZ domain of DVLs. These data indicate that
multiple phosphorylation sites on DVL are required for its binding
to FOXK proteins.
As for the kinases required for the phosphorylation of DVL, we
searched the candidate kinases in the prey lists obtained from
our previous DVL2 and DVL3mass spectrometry analysis. Mem-
bers from the GSK kinase family, CK1 kinase family, and MARK
kinase family were identified in both DVL2 and DVL3 protein
complexes. Although treatment with an inhibitor for CK1 or
MARK (39621) alone partially suppressed the interaction be-
tween DVL and FOXK (Figure 4G), combination treatment with
both a CK1 inhibitor and 39621 further inhibited the FOXK-DVL
association (Figure 4G), suggesting that both CK1 and MARK
may contribute to DVL phosphorylation and its association
with FOXK. Of note, the CK1 family of kinases has been shown
previously to promote DVL phosphorylation, and one of the
members, CK1ε, is activated by Wnt ligand treatment through
DDX3 (Cruciat et al., 2013). Overexpression of CK1ε, but not
its kinase-dead mutant, promoted the binding between DVL
and FOXK (data not shown), supporting our conclusion that
CK1 kinases may contribute to DVL phosphorylation. In the
MARK kinase family, MARK2/PAR1b has been reported to
directly phosphorylate DVL on two serine sites (DVL2, Ser-252
and Ser-259) (Elbert et al., 2006), which are two of the sites iden-
tified by our mutagenesis studies (Figure 4D). This suggests that
the MARK kinases may also contribute to DVL phosphorylation
and DVL-FOXK interaction. However, it remains unknown how
CK1 and MARK kinases are coordinated following Wnt signaling
to phosphorylate DVL and to promote DVL-FOXK complex
formation.
FOXK1 and FOXK2 Are Overexpressed in Human
Colorectal Cancers
Through the analysis of the public gene expression database
(http://www.oncomine.org), we found that FOXK1 and FOXK2
are overexpressed in several types of human cancers, including
CRC (Figure 5A). The expression of FOXK1 is increased in 4 of 34
analyses in CRC compared with normal colon tissue using the
described thresholds (i.e., p % 104, 2-fold change, gene
rank % 10%). FOXK2 expression is also increased in 1 of 36
analyses in CRC compared with normal colon tissue using the
same thresholds. These data, although not very strong, indicate
that FOXK1 and FOXK2 expression may contribute to or facili-
tate CRC development. Given the critical role of Wnt/b-catenin
signaling in CRC, we further examined the correlation of
FOXK1/2 expression and that of the Wnt target gene AXIN2 in
human CRC. Multiple gene expression datasets indicate that
both FOXK1/2 and AXIN2 are upregulated in human colon
cancers (Figure 5B). The expression of FOXK1 and FOXK2
is not controlled by Wnt/b-catenin signaling (data not shown),pmental Cell 32, 707–718, March 23, 2015 ª2015 Elsevier Inc. 713
Figure 4. The Association between DVL and FOXK Is Regulated by Wnt Signaling
(A) Wnt3A promotes the interaction between DVL2 and FOXK1 or FOXK2. HEK293T cells were treated withWnt3A-CM for 8 hr, and cell lysates were subjected to
immunoprecipitation with FOXK1 or FOXK2 antibody, where IgG was taken as a control.
(B) The phosphorylation of DVL2 is required for its association with FOXK2. HEK293T cells were transiently transfected with Myc-DVL2 or SFB-FOXK2, and cell
lysates were subjected to l phosphatase treatment (with or without phosphatase inhibitors) at 30C for 20 min. Cell lysates were combined for the pull-down
assay.
(C) Three FOXK2 site mutations inhibit the association with SDS3 protein. HEK293T cells were transiently transfected for the indicated proteins, and cell lysates
were subjected to a pull-down assay.
(D) Schematic of the amino acid sequence for the FOXK2-binding region on DVL2. Potential phosphorylation sites are labeled in red. Sites close to each other
were categorized into four groups (M1, M2, M3, and M4).
(E and F) Multi-phosphorylation sites located within the 250270 amino acid region of DVL2 are required for the association with FOXK2. HEK293T cells were
transiently transfected with the indicated DVL2 mutants and SFB-FOXK2 for 24 hr, and cell lysates were subjected to a pull-down assay.
(G) The CK1 and MARK2/PAR1 kinases are potential kinases regulating the interaction between FOXK and DVL proteins. HEK293T cells were transfected with
GFP-DVL2 and treatedwith aCK1 inhibitor or theMARK2/PAR1 inhibitor 39621 alone or in combination for 12 hr. Cell lysates were subjected to a pull-down assay
with SFB-FOXK2 cell lysates.indicating that they are not Wnt target genes but, instead, that
their overexpression may contribute to the activation of Wnt/
b-catenin signaling in CRC. Using human colon cancer tissue
arrays, we confirmed that both FOXK1 and FOXK2 were over-
expressed in human colon adenocarcinoma cells compared714 Developmental Cell 32, 707–718, March 23, 2015 ª2015 Elsevierwith normal colon tissues (Figures 5C and 5D). Interestingly,
DVL2 mostly localized in the cytoplasm of normal colon tissue
cells, whereas it displayed nuclear localization in colon adeno-
carcinoma cells (Figures 5C and 5D). Moreover, DVL2 nu-
clear localization correlated to a high expression of FOXK1 orInc.
FOXK2 (Figures 5C and 5D). These data further support the role
of FOXK-mediated DVL nuclear translocation in Wnt signaling
and its involvement in colon cancer formation.
Conditional Expression of Foxk2 Promotes Intestinal
Hyper-Proliferation
Because FOXK1 and FOXK2 have been shown to activate Wnt/
b-catenin signaling and they are overexpressed in human
colon cancers, we wondered whether mimicking FOXK overex-
pression could interfere with intestinal homeostasis using a
genetically engineered mouse model. To conditionally express
FOXK2, we generated doxycycline (+doxy)-inducible Foxk2
transgenic mice: iFoxk2 (TetO-FOXK2-pA) (Figure 5E). For intes-
tine-specific expression of Foxk2, we generated the Villin:Cre-
Rosa26-LSL-rtTA:iFoxk2 mouse strain, which was also allowed
for the doxy-inducible studies (Figure 5E). Villin-Cre is specif-
ically expressed in intestinal epithelial cells (IECs), and this
enabled the conditional expression of Foxk2 in IECs through
Rosa26-LSL-rtTA. Upon doxycycline treatment for 4 months,
the mice with IEC-specific Foxk2 expression (Villin:Cre-
Rosa26-LSL-rtTA:iFoxk2) developed enlarged intestinal crypts
(Figures 5F and 5G). These enlarged crypts featured increased
cell proliferation, as demonstrated by Ki67 staining (Figures 5F
and 5H). These phenotypes in crypts are similar to those
observed in R-Spondin mice (Kim et al., 2005) and APC hetero-
zygous mice (Su et al., 1992), indicating that Wnt/b-catenin
signaling is elevated by Foxk2 expression in crypts. Moreover,
these crypt cells exhibited increased DVL2 nuclear localization
and upregulation of the Wnt/b-catenin target gene CD44 com-
pared with crypts in control mice (Figure 5I). In addition, villus
crypt fractionation indicated that both Foxk1 and Foxk2 are en-
riched in the crypt fractions (Figure 5J). Conditional Foxk2
expression also enhanced the transcription of the Wnt/b-catenin
target genes Lgr5 and Axin2 in intestinal crypt fractions (Fig-
ure 5K). Collectively, these data indicate that Foxk2 overexpres-
sion is sufficient to enhance Wnt/b-catenin signaling and hyper-
proliferation in the mouse intestine.
DISCUSSION
In this study, we identified two FOX transcription factors, FOXK1
and FOXK2, as DVL-interacting proteins, pivotal players in the
Wnt signaling pathway. Our results demonstrated that FOXK1
and FOXK2 positively regulate the canonical Wnt pathway by
promoting the nuclear translocation of DVL. Moreover, FOXK1
and FOXK2 are potential oncoproteins in human colorectal
cancers, as supported by evidence from our transgenic mouse
model and analysis of CRC patient samples.
Our current working hypothesis is that FOXK1 and FOXK2
promote the Wnt signaling pathway by facilitating nuclear local-
ization of DVL, which is independent of b-catenin stabilization
(Figure S2E). Nuclear DVL has been shown to be required
for Wnt/b-catenin signaling by assembling the b-catenin/
TCF/c-Jun transcriptional complex (Gan et al., 2008). DVL nu-
clear translocation is upregulated by Wnt signaling (Gan et al.,
2008; Itoh et al., 2005). However, the mechanism regulating
DVL nuclear translocation was not clear until our study. Here
we show that FOXK1 and FOXK2 are not only sufficient but
also required for DVL nuclear translocation. The interaction be-Develotween FOXK and DVL is critical for this process, and this inter-
action depends on DVL phosphorylation. Wnt signaling en-
hances the association of FOXK with DVL, which is consistent
with its ability to promote DVL nuclear translocation. Moreover,
we also show that the CK1 and MARK kinases are involved in
DVL phosphorylation and the DVL-FOXK interaction, but the
detailed mechanisms remain to be elucidated. Notably, FOXK
nuclear localization is critical for its ability to promote DVL nu-
clear translocation (Figures S2F–S2I) and Wnt signaling activa-
tion (Figure S2J).
Of note is that the Hippo signaling pathway has been re-
ported to participate in the regulation of DVL nuclear localiza-
tion, where cytosolic phospho-YAP/TAZ prevents DVL nuclear
entry (Barry et al., 2013; Varelas et al., 2010). On the basis of
these reports, FOXK and phospho-YAP/TAZ could serve as
the positive and negative regulators, respectively, to govern
DVL nuclear localization. Indeed, expression of the YAP-
S127D mutant (the YAP phosphorylation mimic) suppressed
FOXK-induced TOPFLASH luciferase activity (data not shown).
On the other hand, overexpression of wild-type FOXK2, but not
its L137A mutant, reversed the suppression of DLD-1 tumor
growth mediated by overexpression of the YAP-S127D mutant
(data not shown). In these cases, DVL nuclear translocation
appears to serve as a critical node for the crosstalk between
the Wnt and Hippo pathways because it is positively regulated
by the Wnt-FOXK axis and negatively controlled by the Hippo-
YAP/TAZ axis.
FOXK1 has been identified previously as the key regulator for
myogenic stem cell proliferation and regenerative capability,
which depend on its transcriptional functions (Garry et al.,
2000; Hawke et al., 2003; Meeson et al., 2007; Shi and Garry,
2012). FOXK2 works with AP-1 (c-Jun) as a heterotypic tran-
scriptional complex and regulates c-Jun downstream gene tran-
scription (Ji et al., 2012). These studies indicate that FOXK1and
FOXK2 are required for stem cell maintenance and progenitor
cell proliferation through their transcriptional activities. Our re-
sults indicate that the interaction of FOXK with DVL may also
contribute to FOXK cellular functions, especially in the context
of the Wnt signaling pathway. Nevertheless, the in vivo functions
of FOXKs in the Wnt pathway and during development need to
be elucidated further.
In summary, we identified FOXK1 and FOXK2 as two binding
partners of DVL proteins. FOXK1 and FOXK2 activateWnt/b-cat-
enin signaling by translocating DVL into the nucleus. FOXK1 and
FOXK2 are highly expressed in human colorectal cancers and
correlate with DVL nuclear localization, indicating that FOXK
overexpression may contribute to intestinal tumorigenesis.EXPERIMENTAL PROCEDURES
Antibodies and Plasmids
Information about antibodies, plasmid construction, immunofluorescence
staining, tandem affinity purification, and reverse transcription is provided in
the Supplemental Experimental Procedures.
Cell Culture and Transfection
HEK293T, HeLa, HT29, DLD-1, L Wnt3A (CRL-2647), and L cells (CRL-2648)
were purchased from the ATCC and maintained in DMEM supplemented
with 10% fetal bovine serum (FBS) at 37C in 5% CO2 (v/v). Plasmid transfec-
tion was performed with polyethylenimine reagent.pmental Cell 32, 707–718, March 23, 2015 ª2015 Elsevier Inc. 715
Figure 5. FOXK Proteins Are Pathologically Relevant to Colorectal Cancer Formation
(A and B) FOXK1 and FOXK2 expression was analyzed in silico in human cancers by using the Oncomine database (http://www.oncomine.org). The expression of
FOXK1 and FOXK2 was analyzed in various human cancers (A). The co-expression among AXIN2, FOXK1, and FOXK2was analyzed in human colorectal cancer
datasets (GSE5206 and TCGA) (B). The Oncomine analysis settings used were as follows: 10% gene rank, p value < 0.0001, fold change > 2.
(C and D) FOXK expression and DVL nuclear localization are correlated positively in human colon cancers. Immunohistochemical staining of FOXK1, FOXK2, and
DVL2 was performed in representative normal colon and colon carcinoma samples (C). Brown staining indicates positive immunoreactivity. The indicated regions
in the box are shown enlarged below. Correlation analyses between FOXK1/ FOXK2 levels and DVL2 nuclear localization in human normal colon and colon
carcinoma samples are shown (D). Statistical significance was determined by chi-square test. R, correlation coefficient.
(E) Schematic of the generation-inducible mFoxk2mousemodel (iFoxk2). Upon doxycycline administration via drinking water, Foxk2 is conditionally expressed in
the intestinal epithelium by crossing with the Vilin-Cre and Rosa26-LSL-rtTAmouse strains. Rosa26-LSL-rtTA: iFoxk2was taken as control group (Foxk2 off) and
Vilin-Cre:Rosa26-LSL-rtTA:iFoxk2 was taken as the experimental group (Foxk2 on). Mice were given doxycycline-containing drinking water for 4 months. rtTA,
reverse tetracycline transactivator; TetO, tetracycline operator; pA, poly-A tail signal.
(F) Foxk2 overexpression promotes the proliferation of mouse intestine. Ki67 staining is shown for representative images. The indicated regions in the box are
shown enlarged below.
(G and H) Nearly 50 crypts from control and Foxk2 overexpression mice were chosen randomly for the analysis of crypt length (G) and Ki67-positive cells (n = 48
crypts, mean ± SD) (H).
(I) Induction of Foxk2 promotes the nuclear translocation of Dvl2 in the intestine crypt and upregulates Wnt/b-catenin signaling. DVL2 and CD44 staining are
shown. Arrows indicate the Dvl2 localization in the crypt.
(legend continued on next page)
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Axis Duplication Assay
Embryo preparation, in vitro fertilization, and microinjections were performed
according to standard methods (Fang et al., 2004). mRNAs for microinjection
were generated using in vitro mMessage mMachine (Ambion). Xenopus b-cat-
enin (60 pg), and the indicatedmRNAs were co-injected into one ventrovegetal
blastomere of four-cell embryos. The secondary axis duplication was counted
at embryonic stages 18–35.
Xenograft Assays
All mouse experiments followed institutional guidelines, were approved by the
Institutional Animal Care andUseCommittee of theMDAnderson Cancer Cen-
ter and performed under veterinary supervision. Four-week-old female nude
mice were kept in a pathogen-free environment and injected subcutaneously
with 23 106 HT29 or DLD-1 cells. After 15 days for adaptation, tumor weights
were analyzed, and immunohistochemistry was performed.
Transgenic Animals
As described previously (Jung et al., 2013), a TetO minimal promoter-mFoxk2-
BGHpA DNA fragment was injected into the pronucleus of the zygotes to
generate transgenic iFoxk2 mice in the Genetically Engineered Mouse Facility
(MD Anderson Cancer Center). iFoxk2 pups from two independent founder
strains were utilized for analysis. Foxk2 transgene expression was induced
by doxycycline administration (2 g/l, 5% sucrose in drinking water) in the suc-
cessive generations crossed with C57BL/6 mice. All mice were maintained ac-
cording to the institutional guidelines and Association for Assessment and
Accreditation of Laboratory Animal Care international standards.
Villus Crypt Fractionation
For villus-crypt isolation, mouse intestine was collected, washed with
Ca2+Mg2+-free PBS (Gibco) and cut into 1-cm pieces. Incised intestine was
incubated with ice-cold Ca2+Mg2+-free PBS containing 1mM EDTA and
1mM EGTA for 2 min. After gentle shaking, the supernatant was collected as
a sequential fraction by passage through a 70-mm cell strainer. Then collected
villus-crypt fractions were pelleted and processed for RNA extraction using
TRIzol. Primer sequences for real-time PCR analysis were as follows: Gapdh
forward, 50-TGTTCCTACCCCCAATGTGT-30; Gapdh reverse, 50-TGTGAGG
GAGATGCTCAGTG-30; Foxk1 forward, 50-GGGAGTTCGAGTTCCTGATG-30;
Foxk1 reverse, 50-AGAAGTGAGGCTCCTGGAAG-30; Foxk2 forward, 50-
TGCAATTAGCCCAGCTACAC-30; Foxk2 reverse, 50-TGGAAGCTGGTGTT
GACCTA-30; Lgr5 forward, 50-CCACAGCAACAACATCAGGT-30; Lgr5 reverse,
50-AACAAATTGGATGGGGTTGT-30; Axin2 forward, 50-AAGCCTGGCTCCA
GAAGATCACAA-30; Axin2 reverse, 50-TTTGAGCCTTCAGCATCCTCCTGT-30.
Immunohistochemistry
The colon tissue array was purchased from US Biomax. Samples were depar-
affinized and rehydrated. Then antigens were retrieved by applying Unmask
solution (Vector Laboratories) in a steamer for 30 min. The sections were
treated with 1% hydrogen peroxide in methanol for 30 min to block endoge-
nous peroxidase activity. After 1 hr of pre-incubation in 10%goat serum to pre-
vent non-specific staining, the samples were incubated with an antibody at
4C overnight. The sections were incubated with SignalStain Boost detection
reagent for 30min at room temperature. Color was developed with SignalStain
3,30-diaminobenzidine chromogen-diluted solution (all reagents were obtained
fromCell Signaling Technology). Sections were counterstained withMayer he-
matoxylin. Pearson chi-square analysis test was used for statistical analysis of
the correlation of FOXK1, FOXK2, or nuclear DVL2 with tissue type (normal
versus cancer) and the correlation between FOXK1/2 and nuclear DVL2.
Statistical Analysis
We did not exclude any samples or animals from the analysis. Data were
analyzed by Student’s t test and Pearson chi-square analysis. SD was used
for error estimation. A p value pf <0.05 was considered statistically significant.(J and K)Wnt/b-catenin activation was induced in the intestine crypt of mice by co
and crypt fractions (n = 3, mean ± SD) (J). The transcription of Wnt/b-catenin-t
experimental mice (n = 3, mean ± SD) (K).
*p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test).
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